Abeona Therapeutics Inc. (ABEO)
NASDAQ: ABEO · Real-Time Price · USD
6.01
-0.20 (-3.22%)
At close: Aug 26, 2026, 4:00 PM EDT
6.01
0.00 (0.00%)
After-hours: Aug 26, 2026, 4:00 PM EDT
Abeona Therapeutics Market Cap
Abeona Therapeutics has a market cap or net worth of $343.96 million as of August 26, 2026. Its market cap has decreased by -4.32% in one year.
Market Cap
343.96M
Enterprise Value
217.01M
1-Year Change
-4.32%
Ranking
Category
Stock Price
$6.01
ChartMarket Cap Chart
Since March 30, 2000, Abeona Therapeutics's market cap has increased from $78.00M to $343.96M, an increase of 340.98%. That is a compound annual growth rate of 5.78%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 26, 2026 | 343.96M | 20.43% |
| Dec 31, 2025 | 285.60M | 17.97% |
| Dec 31, 2024 | 242.10M | 95.08% |
| Dec 29, 2023 | 124.10M | 134.59% |
| Dec 30, 2022 | 52.90M | 54.23% |
| Dec 31, 2021 | 34.30M | -77.83% |
| Dec 31, 2020 | 154.70M | -7.53% |
| Dec 31, 2019 | 167.30M | -51.12% |
| Dec 31, 2018 | 342.30M | -53.83% |
| Dec 29, 2017 | 741.40M | 282.56% |
| Dec 30, 2016 | 193.80M | 76.18% |
| Dec 31, 2015 | 110.00M | 5,689.47% |
| Dec 31, 2014 | 1.90M | -70.31% |
| Dec 31, 2013 | 6.40M | 10.34% |
| Dec 31, 2012 | 5.80M | -82.63% |
| Dec 30, 2011 | 33.40M | -15.87% |
| Dec 31, 2010 | 39.70M | -7.89% |
| Dec 31, 2009 | 43.10M | 563.08% |
| Dec 31, 2008 | 6.50M | -43.97% |
| Dec 31, 2007 | 11.60M | 17.17% |
| Dec 29, 2006 | 9.90M | 7.61% |
| Dec 30, 2005 | 9.20M | -83.24% |
| Dec 31, 2004 | 54.90M | -21.57% |
| Dec 31, 2003 | 70.00M | 255.33% |
| Dec 31, 2002 | 19.70M | -65.50% |
View and export this data all the way back to 2000. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lyell Immunopharma | 379.58M |
| Agenus | 376.37M |
| Zentalis Pharmaceuticals | 367.33M |
| DiaMedica Therapeutics | 363.46M |
| InflaRx | 362.53M |
| Palisade Bio | 360.74M |
| Sutro Biopharma | 355.50M |
| SAB Biotherapeutics | 346.66M |